BMD
GILD icon

Better Money Decisions’s Gilead Sciences GILD Stock Holding History

Better Money Decisions’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-300
Closed -$19K – 200
2022
Q2 		$19K Buy
+300
New +$18.6K 0.02% 235
2021
Q4 		– Sell
-300
Closed -$21K – 268
2021
Q3 		$21K Hold
300
– – 0.02% 272
2021
Q2 		$21K Buy
300
+252
+525% +$16.8K 0.02% 260
2021
Q1 		$3K Buy
+48
New +$3.1K ﹤0.01% 520

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Better Money Decisions's GILD Position: Q3 2022 in Review

Better Money Decisions sold out of Gilead Sciences (GILD) in Q3 2022, closing a stake of 300 shares — an estimated $19K sold.

Better Money Decisions first reported a position in GILD in Q1 2021 and held it in 4 quarters. The position peaked at $21K in Q3 2021. 1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

  • Better Money Decisions reported no remaining Gilead Sciences position as of Q3 2022 after selling out during the quarter.
  • Better Money Decisions sold 300 Gilead Sciences shares in Q3 2022, an estimated $19K.
  • Better Money Decisions first reported a position in Gilead Sciences in Q1 2021 and held it in 4 quarters.
  • Better Money Decisions's Gilead Sciences position peaked at $21K in Q3 2021.
  • 1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on Better Money Decisions's 13F filing for Q3 2022, filed 28 Oct 2022.